Maleimide is one of the most widely used electrophilic functional groups in bioconjugation chemistry. Its high selectivity for thiol groups at physiological pH makes it indispensable for constructing antibody-drug conjugates (ADCs), labeling proteins at specific cysteine residues, and building complex multifunctional bioconjugates. This guide covers the fundamentals of maleimide chemistry — from its molecular structure and reaction mechanism to practical applications with PEG-maleimide reagents.
Chemical Structure of Maleimide
Maleimide (1H-pyrrole-2,5-dione) is a five-membered heterocyclic ring containing a nitrogen atom flanked by two carbonyl groups and an alkene. Its molecular formula is C₄H₃NO₂, with a molecular weight of 97.07 g/mol. The parent compound is a white to off-white crystalline solid with a melting point of 92–94°C, soluble in water, ethanol, and most polar organic solvents.
The key structural features that drive maleimide’s reactivity:
- Electron-deficient alkene: The two adjacent carbonyls withdraw electron density from the C=C double bond, making it strongly electrophilic. This electronic activation lowers the LUMO energy of the alkene, making it an excellent acceptor for nucleophilic Michael addition.
- Ring strain: The cis configuration of the double bond within the five-membered ring adds modest ring strain, further activating the alkene toward nucleophilic addition. The endocyclic double bond is locked in the cis (Z) configuration by the ring geometry, providing a rigid, pre-organized electrophilic site.
- N-substitution site: The nitrogen atom serves as the attachment point for linkers, PEG chains, and other molecular scaffolds. N-substituted maleimides retain full thiol reactivity while enabling modular reagent design. Common N-substituents include alkyl chains, PEG linkers, aromatic groups, and complex linker-payload architectures for ADC applications.
The planar geometry of the maleimide ring positions the double bond in an optimal orientation for Michael addition reactions. This geometric constraint — combined with the strong electron withdrawal — gives maleimide reaction rates with thiols that are approximately 1,000-fold faster than with amines at neutral pH. The compound absorbs UV light weakly around 300 nm, which can be useful for monitoring reaction progress spectrophotometrically, though this absorption overlaps with protein signals at higher wavelengths.
Thiol-Maleimide Reaction Mechanism
The thiol-maleimide reaction is a Michael-type addition: a thiolate anion (RS⁻) attacks the β-carbon of the maleimide’s electron-deficient double bond. The mechanism proceeds as follows:
Step 1 — Thiolate formation: At pH values above ~7, the cysteine side chain (pKₐ ≈ 8.3 for free cysteine, though local protein environment can shift this to 6–9) exists partially as the thiolate anion. The thiolate is the active nucleophile — the protonated thiol (RSH) reacts orders of magnitude more slowly.
Step 2 — Conjugate addition: The thiolate attacks one of the two equivalent olefinic carbons of the maleimide ring, forming a new C–S bond. This is a concerted but asynchronous process, with the transition state resembling a classical Michael addition.
Step 3 — Protonation: The resulting enolate intermediate is rapidly protonated by solvent or buffer to yield the stable thiosuccinimide product.
The overall reaction is:
R-SH + Maleimide → Thiosuccinimide adduct
This reaction is fast (second-order rate constants on the order of 10²–10⁴ M⁻¹s⁻¹ at pH 7), quantitative under mild conditions, and proceeds without catalysts or coupling reagents. These properties make it one of the cleanest bioconjugation reactions available.
Reactivity and Selectivity: What Makes Maleimide Special
The value of maleimide chemistry in bioconjugation rests on its selectivity profile:
Thiol selectivity at physiological pH
At pH 6.5–7.5, maleimides react almost exclusively with sulfhydryl groups. Amine nucleophiles (lysine ε-amino groups, N-terminus) react with maleimide at rates roughly 1,000× slower than thiols at this pH range. This kinetic selectivity allows site-specific modification of proteins at cysteine residues without significant off-target amine labeling.
Comparison with other thiol-reactive groups
| Reactive Group | Target | Rate (relative) | Selectivity | Stability |
|---|---|---|---|---|
| Maleimide | Thiols | Fast (1,000×) | High at pH 6.5–7.5 | Moderate (hydrolysis-prone) |
| Iodoacetamide | Thiols | Moderate | Moderate | Good |
| Vinyl sulfone | Thiols | Slow | Moderate–High | Excellent |
| Disulfide (pyridyl) | Thiols | Fast | High | N/A (exchange) |
Why not just use iodoacetamide?
Iodoacetamides are also thiol-selective, but they react via an SN2 mechanism, producing a thioether that is irreversible and stable. However, maleimide offers faster kinetics and cleaner reaction profiles. The trade-off is that the thiosuccinimide product can undergo retro-Michael reactions or ring-opening hydrolysis — a consideration for long-term stability (discussed below).
Maleimide Hydrolysis and Stability Considerations
The maleimide ring is susceptible to hydrolysis, and this has important practical implications:
Unreacted maleimide hydrolysis
In aqueous solution, the unreacted maleimide ring can hydrolyze to maleamic acid (ring-opened form). This reaction is pH- and temperature-dependent: – Half-life at pH 7.4, 37°C: Approximately 2–4 hours for typical N-alkyl maleimides – Accelerated above pH 8: Hydrolysis rate increases significantly
Once hydrolyzed, the maleimide can no longer react with thiols. This means reagents should be stored dry, and conjugation reactions should be completed promptly after dissolving maleimide-containing reagents in aqueous buffers.
Thiosuccinimide ring opening
After conjugation, the thiosuccinimide adduct itself can undergo ring opening (hydrolysis of one of the two amide bonds in the succinimide ring). This produces two isomeric ring-opened forms. Importantly:
- Ring-opened products are resistant to retro-Michael elimination. The succinimide thioether linkage can undergo retro-Michael reaction (releasing the thiol), but the ring-opened form cannot. This is why deliberate hydrolysis of the succinimide ring post-conjugation has become standard practice in ADC manufacturing — it locks the conjugation in place.
- Intentional ring opening is typically achieved by raising the pH to 8.5–9.0 after conjugation or by using N-aryl maleimides, which hydrolyze more readily.
These stability dynamics are well-characterized in the ADC field, where linker stability in plasma directly affects therapeutic index.
PEG-Maleimide Reagents: Bridging Chemistry and Biology
PEG-maleimide reagents combine the thiol-selective reactivity of maleimide with the pharmacokinetic advantages of polyethylene glycol (PEG). These bifunctional molecules contain a maleimide group on one end and various functional groups on the other, connected through a defined PEG spacer.
Why add a PEG spacer?
- Solubility: PEG chains increase the water solubility of hydrophobic payloads and improve the solubility profile of the entire conjugate.
- Steric shielding: PEG creates a hydrophilic corona around the conjugation site, reducing immunogenicity and proteolytic degradation.
- Pharmacokinetics: PEGylation extends circulation half-life by reducing renal clearance and shielding from opsonization.
- Defined molecular weight: Monodisperse PEG spacers (as supplied by PurePEG) eliminate the batch-to-batch variability inherent in polydisperse PEG, enabling reproducible drug-to-antibody ratios (DAR) and cleaner analytical characterization.
Common PEG-maleimide architectures
| Architecture | Example | Application |
|---|---|---|
| mPEG-Maleimide | mPEG45-NH-Mal | PEGylation of thiol-bearing proteins |
| Maleimide-PEG-NHS | Maleimide-NH-PEG45-CH₂CH₂COONHS Ester | Heterobifunctional crosslinking (thiol + amine) |
| Maleimide-PEG-COOH | Maleimide-PEG8-CH₂CH₂COOH | Conjugation with subsequent amide coupling |
| Maleimide-PEG-Payload | Mal-PEG8-Val-Cit-PAB-MMAE | ADC payload attachment via cleavable linker |
PurePEG’s catalog of heterobifunctional PEG linkers includes monodisperse maleimide-PEG reagents spanning PEG4 through PEG45, giving researchers precise control over spacer length and hydrophilicity.
For a deeper look at how PEG linker selection affects conjugate performance, see our guide on applications of PEGylated linkers in bioconjugation.
Applications of Maleimide in Bioconjugation
Maleimide applications span nearly every area of modern bioconjugation. The key application domains include:
Protein labeling and detection
Maleimide-functionalized fluorophores, biotin tags, and affinity handles are standard tools for labeling proteins at free or engineered cysteine residues. Unlike amine-reactive labels (which modify multiple lysines non-specifically), maleimide labeling targets a single or small number of defined sites, yielding conjugates with predictable stoichiometry.
Antibody-drug conjugates (ADCs)
The majority of clinically approved ADCs use maleimide-thiol chemistry to attach cytotoxic payloads to antibody cysteine residues. The canonical approach involves partial reduction of interchain disulfide bonds to expose free thiols, followed by conjugation with maleimide-bearing linker-payload constructs.
Key considerations for ADC applications: – DAR control: Partial reduction typically yields DAR 2, 4, or 8 species. Engineered cysteine mutants (THIOMABs) enable homogeneous DAR 2 conjugates. – Linker stability: As discussed above, thiosuccinimide hydrolysis (ring-opening) is now routinely used to prevent premature payload release in circulation. – Payload release: Cleavable linkers like Val-Cit-PAB incorporate a maleimide attachment point and a cathepsin-cleavable dipeptide for intracellular drug release.
For a comprehensive overview of ADC linker strategies, see our ADC linker technology overview.
Surface modification and biomaterial functionalization
Maleimide-functionalized surfaces enable oriented immobilization of thiol-bearing biomolecules — antibodies, peptides, oligonucleotides with thiol modifications — on gold, glass, and polymer substrates. This approach preserves biological activity better than random adsorption or amine coupling.
PEGylation of therapeutic proteins
mPEG-maleimide reagents provide site-specific PEGylation at engineered or native cysteine residues. Compared to amine-directed PEGylation (using NHS-PEG), thiol-directed PEGylation yields more homogeneous products with better-preserved biological activity.
Bispecific antibodies and multi-specific constructs
Maleimide chemistry enables the controlled assembly of bispecific antibodies from two half-antibodies, each bearing complementary reactive groups. The selectivity and speed of the thiol-maleimide reaction facilitates efficient assembly at the inter-chain cysteine sites.
Oligonucleotide conjugation
Synthetic oligonucleotides (siRNA, ASOs, aptamers) are readily functionalized with thiol groups during solid-phase synthesis. Maleimide-PEG or maleimide-lipid reagents then enable conjugation for delivery applications — attaching targeting ligands, PEG shields, or lipid anchors to nucleic acid therapeutics. This approach is widely used in siRNA-GalNAc conjugates and lipid nanoparticle formulations.
Nanoparticle functionalization
Gold nanoparticles, quantum dots, and polymeric nanoparticles bearing surface thiols can be functionalized with maleimide-bearing molecules — antibodies, peptides, carbohydrates, or PEG chains. The thiol-maleimide reaction proceeds under mild aqueous conditions compatible with nanoparticle stability, and the fast kinetics minimize exposure to conditions that might cause particle aggregation.
Maleimide in Antibody-Drug Conjugate Development
ADC development represents the most commercially significant application of maleimide reactivity. As of 2026, over a dozen FDA-approved ADCs utilize maleimide-based conjugation chemistry, and hundreds more are in clinical trials.
The standard maleimide-cysteine approach
The conventional workflow:
- Partial reduction of IgG interchain disulfides with TCEP or DTT (typically 2–4 equivalents) to generate 2–8 free thiols per antibody.
- Conjugation with a maleimide-linker-payload construct (e.g., MC-Val-Cit-PAB-MMAE or Mal-PEG8-Val-Cit-PAB-MMAE) at pH 6.5–7.0.
- Quenching of unreacted maleimide groups (typically with excess N-acetyl cysteine).
- Purification by SEC, HIC, or tangential flow filtration to remove aggregates and free drug.
- Optional succinimide ring hydrolysis at elevated pH to lock the conjugation.
PEG spacers in ADC linkers
Incorporating a monodisperse PEG spacer between the maleimide and the payload improves: – Solubility of hydrophobic payloads (MMAE, MMAF, DM1) – Pharmacokinetics — reduced aggregation, improved circulation – Bystander killing for cleavable linkers in heterogeneous tumors
PurePEG’s cleavable linker catalog includes ADC-ready maleimide constructs with Val-Cit-PAB cleavable motifs and defined PEG spacers.
Next-generation approaches
Emerging strategies address the limitations of conventional maleimide conjugation: – Stabilized maleimides: Self-hydrolyzing maleimides (e.g., N-aryl maleimides with electron-donating substituents) that spontaneously ring-open after conjugation, preventing retro-Michael deconjugation. This approach eliminates the need for a separate hydrolysis step in manufacturing. – Bridging maleimides: Dibromomaleimides and dithiomaleimides that re-bridge reduced disulfides, maintaining antibody structural integrity while attaching payloads. These reagents insert into the disulfide bond rather than capping individual thiols, yielding homogeneous DAR 1 per disulfide site. – Site-specific conjugation: Engineered cysteines positioned in solvent-exposed loops (the THIOMAB approach pioneered by Genentech) for homogeneous DAR 2 conjugates. These mutations introduce a single reactive cysteine per heavy chain at positions that don’t disrupt antibody folding or function. – Dual-payload conjugation: Combining maleimide chemistry with orthogonal reactions (DBCO-azide click chemistry, for example) on the same antibody allows attachment of two different payloads at distinct sites — opening the door to synergistic drug combinations on a single ADC scaffold.
Choosing the Right Maleimide Reagent
Selecting the appropriate maleimide reagent depends on your specific application, the nature of your biomolecule, and the desired conjugate properties.
Key decision factors
| Factor | Consideration |
|---|---|
| Target functional group | Maleimide for thiols; consider NHS esters if targeting amines (see our maleimide vs NHS ester comparison) |
| PEG spacer length | Shorter PEGs (PEG4–PEG8) for compact linkers; longer PEGs (PEG24–PEG45) for solubility and shielding |
| Second functional group | NHS ester for amine coupling, DBCO for click chemistry, COOH for EDC/NHS activation |
| Cleavable vs stable | Val-Cit-PAB for intracellular cleavage; stable thioether for permanent conjugation |
| Monodispersity | Always prefer monodisperse PEG for reproducible conjugates and clean analytical profiles |
Recommended reading
This pillar page connects to our detailed cluster articles on maleimide chemistry:
- Top 10 Maleimide-PEG Reagents for Bioconjugation in 2026 — A curated selection of the most versatile maleimide-PEG products, with specifications and use cases.
- Maleimide-Thiol Conjugation: Protocol, Tips & Troubleshooting Guide — Step-by-step protocol with buffer conditions, stoichiometry, and solutions for common problems.
- Maleimide vs NHS Ester: Choosing the Right Reactive Group — Side-by-side comparison of the two most common bioconjugation chemistries.
- 5 Ways to Improve Maleimide Conjugation Efficiency — Practical optimization strategies for maximizing yield and minimizing side reactions.
Frequently Asked Questions
What pH is optimal for maleimide-thiol conjugation?
The optimal pH range is 6.5–7.5. Below pH 6.5, thiolate concentration is too low for efficient reaction (cysteine pKₐ ≈ 8.3, so only a small fraction is deprotonated). Above pH 7.5, competing maleimide hydrolysis becomes significant, and amine side reactions increase. pH 7.0 in phosphate buffer represents the best balance of reactivity and selectivity for most applications.
How fast does maleimide react with cysteine?
Under typical conditions (pH 7.0, room temperature, low micromolar concentrations), the thiol-maleimide reaction reaches completion within 15–60 minutes. At higher concentrations (millimolar range), the reaction can be essentially complete in under 5 minutes. The second-order rate constant is approximately 500–5,000 M⁻¹s⁻¹ depending on the specific maleimide and thiol.
Is the maleimide-thiol bond reversible?
The thiosuccinimide product can undergo retro-Michael elimination, especially in the presence of competing thiols (such as glutathione in plasma). The rate of this reverse reaction depends on the local environment and pH. Ring-opening hydrolysis of the succinimide converts the linkage to a stable, non-reversible thioether — this is why intentional hydrolysis post-conjugation is now standard in ADC manufacturing.
What is the difference between maleimide and NHS ester reactivity?
Maleimide reacts selectively with thiols (cysteine residues), while NHS esters react with primary amines (lysine residues, N-terminus). Maleimide offers site-specific conjugation (fewer cysteines than lysines on most proteins), while NHS esters provide broader but less specific labeling. For a detailed comparison, see our article on maleimide vs NHS ester chemistry.
Can maleimide be used for click chemistry?
Maleimide is not a click chemistry reagent in the strict sense (CuAAC or SPAAC). However, PurePEG offers dual-functional reagents like DBCO-CONH-PEG44-Mal that combine maleimide (for thiol conjugation) and DBCO (for strain-promoted azide-alkyne click chemistry) on a single molecule. This enables orthogonal, sequential bioconjugation strategies.
PurePEG provides monodisperse PEG-maleimide reagents with defined molecular weights and up to 98%+ purity. Explore our full catalog of heterobifunctional PEG linkers or contact our PEG specialists at 1-888-331-8188 to discuss your maleimide conjugation project.